Opioid Market on Track to Attain USD 26.41 Billion by 2032, Fueled by a 1.5% CAGR | Key Players- Cadila Healthcare Limited, Fresenius Kabi, Mallinckrodt Pharmaceuticals

𝐎𝐩𝐢𝐨𝐢𝐝 𝐦𝐚𝐫𝐤𝐞𝐭 𝐬𝐢𝐳𝐞 𝐰𝐚𝐬 𝐯𝐚𝐥𝐮𝐞𝐝 𝐚𝐭 𝐔𝐒𝐃 𝟐𝟑.𝟏𝟎 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟐𝟑. 𝐓𝐡𝐞 𝐨𝐩𝐢𝐨𝐢𝐝 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐢𝐬 𝐩𝐫𝐨𝐣𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐠𝐫𝐨𝐰 𝐭𝐨 𝐔𝐒𝐃 𝟐𝟔.𝟒𝟏 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟐, 𝐞𝐱𝐡𝐢𝐛𝐢𝐭𝐢𝐧𝐠 𝐚 𝐜𝐨𝐦𝐩𝐨𝐮𝐧𝐝 𝐚𝐧𝐧𝐮𝐚𝐥 𝐠𝐫𝐨𝐰𝐭𝐡 𝐫𝐚𝐭𝐞 (𝐂𝐀𝐆𝐑) 𝐨𝐟 𝟏.𝟓% 𝐝𝐮𝐫𝐢𝐧𝐠 𝐭𝐡𝐞 𝐟𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐩𝐞𝐫𝐢𝐨𝐝 (𝟐𝟎𝟐𝟒 - 𝟐𝟎𝟑𝟐).

𝐌𝐚𝐫𝐤𝐞𝐭 𝐃𝐞𝐟𝐢𝐧𝐢𝐭𝐢𝐨𝐧:

Opioids, a class of psychoactive medications also known as painkillers, work by binding to opioid receptors on nerve cells in the brain, spinal cord, and other regions of the body to reduce pain. Physicians prescribe a variety of opioids in varying dosages that can be taken in a variety of ways based on the patient, the circumstance, and the kind and intensity of pain. It is anticipated to rise significantly during the projection period due to its significant importance to the healthcare sector.

𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐰𝐢𝐭𝐡 𝐨𝐮𝐫 𝐄𝐱𝐜𝐥𝐮𝐬𝐢𝐯𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.polarismarketresearch.com/industry-analysis/opioid-market/request-for-sample

𝐆𝐫𝐨𝐰𝐭𝐡 𝐃𝐫𝐢𝐯𝐞𝐫𝐬 𝐚𝐧𝐝 𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬:

• The increased prevalence of chronic diseases such as cancer and diabetes, among others, is propelling market expansion throughout the predicted period.
• The opioid market is expected to increase steadily as chronic illnesses become more prevalent. As the elderly population chooses painkiller approaches, the market for pain suppressants is expected to expand significantly.

𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬:

Because there are so many companies in the industry, it is expected to be both competitive and fragmented. Here is the list of the leading companies operating in the market:
• Aurobindo Pharma Limited
• Assertio Therapeutics
• Inc.
• AbbVie Inc.
• Actavis Plc.
• Amneal Pharmaceuticals LLC, Boehringer Ingelheim International GmbH
• Cadila Healthcare Limited
• Fresenius Kabi
• Mallinckrodt Pharmaceuticals
• Endo International plc
• Johnson & Johnson Corporation
• Lupin Limited
• Nesher Pharmaceuticals (USA) LLC
• Purdue Pharma L.P.
• Pfizer Inc.
• Rhodes Pharmaceuticals L.P.

𝐂𝐥𝐢𝐜𝐤 𝐨𝐧 𝐭𝐡𝐞 𝐁𝐞𝐥𝐨𝐰 𝐋𝐢𝐧𝐤 𝐭𝐨 𝐁𝐮𝐲 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.polarismarketresearch.com/buy/1560/2

𝐓𝐫𝐞𝐧𝐝𝐬:

• Opioid Crisis Impact: The ongoing opioid crisis has led to increased scrutiny and regulation of opioid prescribing practices. There is a strong emphasis on addressing addiction and providing support for individuals with substance use disorders.
• Development of Abuse-Deterrent Formulations: Pharmaceutical companies are focusing on developing abuse-deterrent formulations to minimize the risk of misuse and addiction.
• Growth of Non-Opioid Pain Management: Increased interest in alternative therapies and non-opioid pain management options, such as NSAIDs, physical therapy, and complementary medicine.
• Advancements in Drug Delivery Systems: Innovations in drug delivery systems, such as transdermal patches and extended-release formulations, to improve pain management and reduce the risk of abuse.

𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐎𝐮𝐭𝐥𝐨𝐨𝐤:

• North America (U.S., Canada)
• Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
• Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)
• Latin America (Brazil, Mexico, Argentina)
• Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

𝐁𝐫𝐨𝐰𝐬𝐞 𝐅𝐮𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭 𝐂𝐥𝐢𝐜𝐤 𝐇𝐞𝐫𝐞: https://www.polarismarketresearch.com/industry-analysis/opioid-market

𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰:

The opioid market is mainly segmented based on class, release type, product, application, and region. Based on the release type research, the extended-release market is likely to experience the most rapid growth. ER, analgesics give more dependable and increased nocturnal pain control, reducing the need for patients with chronic noncancer pain to get up in the middle of the night to take another dose of pain medication and requiring less clock-watching on their side. Because of its broad usage in treating chronic pain, ER is the fastest-growing category.

Furthermore, according to the application analysis, pain management has the largest market share and is expected to maintain that position over the forecast period. This market is expected to expand rapidly due to an increase in the number of people suffering from chronic headaches and back pain, patients recovering from surgery or enduring terrible pain from cancer, and persons injured while engaging in sports, auto accidents, or other mishaps.

𝐎𝐩𝐢𝐨𝐢𝐝 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬

• The long-acting opioids segment is anticipated to grow at the highest CAGR over the forecast period. These drugs are frequently used to treat moderate to severe chronic pain. These medications offer therapeutic advantages such as consistent, long-lasting analgesia and reduced dose frequency.

• Semi-synthetic opioids segment accounted for to growth rapidly of the global revenue share due to the increased availability and demand for these painkillers. Labs use natural opiates to create semi-synthetic types.

• Asia-Pacific is expected to grow prominently over the projected period. This can be attributed to cancer cases rising across several developing economies. Nearly half of cancer's worldwide burden is borne by Asia. Additionally, a growing elderly population and an increase in cases of chronic pain would increase regional market demand.

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐖𝐢𝐝𝐞-𝐫𝐚𝐧𝐠𝐢𝐧𝐠 𝐂𝐨𝐯𝐞𝐫𝐚𝐠𝐞 𝐨𝐟 𝐏𝐌𝐑'𝐬 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐋𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞:

Tumor Ablation Market: https://www.polarismarketresearch.com/industry-analysis/global-tumor-ablation-market

Drug Discovery Informatics Market: https://www.polarismarketresearch.com/industry-analysis/drug-discovery-informatics-market

Xerostomia Therapeutics Market: https://www.polarismarketresearch.com/industry-analysis/xerostomia-therapeutics-market

Anesthesia Devices Market: https://www.polarismarketresearch.com/industry-analysis/global-anesthesia-devices-Market

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬:

Polaris Market Research
Phone: +1-929-297-9727
Email: sales@polarismarketresearch.com

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

This release was published on openPR.